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Magnifying Stem Cell Lineages
The Stop-EGFP Mouse
ABSTRACT
Cell fate mapping techniques which can label clonal cell lineages are of importance
because they allow one to investigate the distribution and types of daughter cells arising
from single precursor cells. Thus, the potential of precursor cells to generate various types
of descendent cells can be studied at the single-cell level. The stop-EGFP transgenic mouse
carries a premature stop codon-containing enhanced green fluorescent protein (EGFP)
gene as a target gene for mutations. A cell having undergone a mutation at the premature
stop codon and its descendant cell lineage will express EGFP, thus a clonal cell lineage
can be traced in vivo using a fluorescent microscope. Using the stop-EGFP mouse, stem
cell clonal lineages in the mouse dorsal epidermis can be investigated in vivo and repeated
analyses of the same cell lineages can be performed over time. In vivo imaging studies
possible with the stop-EGFP mouse provide new insights into the structure of epidermal
proliferative units (EPUs). The stop-EGFP system provides a novel tool for investigating
clonal cell lineages in developmental studies as well as in stem cell biology.
Investigation of the distribution and the types of daughter cells that individual precur-
sor cells give rise to is of great importance not only in developmental studies but also in
stem cell biology. Recent studies imply that stem cells in an adult tissue, which have long
been thought to produce only limited cell types in a given tissue, have the capability to
produce even cells of developmentally unrelated tissue types in experimentally modified
conditions.1-4 To determine how diverse a range of cell types and how expansive a clonal
cell lineage a single stem cell of a particular tissue can produce, a fate mapping technique
that allows one to trace clonal cell lineages in a mammalian system in vivo is required.
Although various mapping techniques have been developed so far, labeling of single cells
is difficult to achieve and very few systems have been efficiently applied to fate mapping
of single precursor cells (Table 1).5,6 Green fluorescent protein (GFP) has proven to be a
versatile marker in developmental studies for various organisms.7-10 An advantage of using
GFP is that imaging of GFP does not require any substrate or cofactor, or any fixation
process which necessitates sacrifice of tissue or animal. Thus, one can perform live imaging
of GFP-expressing cells, real-time imaging, or repeated imaging of GFP-labeled cells over
time.7,9 Direct imaging of GFP can also avoid possible artifacts which might be introduced
during the process of tissue fixation.8
Recently, a transgenic mouse system was developed to allow in vivo imaging of clonal
cell lineages via GFP.11 Individual cells are labeled by means of random mutation and cell
lineages that descended from the labeled single cells express GFP, such that clonal cell
lineages can be traced in vivo. A plasmid designed to express EGFP (enhanced GFP) ubiq-
uitously12 was modified by introducing a premature stop codon (TAG) at a neutral codon
site. A mutation at any one of the three nucleotides of the stop codon can restore EGFP
function (except in the case of a mutation from G to A at the third site, which produces
another stop codon, TAA) because any substitution for amino acid encoded by a codon at
a neutral site does not affect the protein function. The fact that multiple copies of a trans-
gene are usually inserted in a linear array in a transgenic mouse increases the efficiency of
this system for detecting mutations. The stop-EGFP transgenic mouse that we have devel-
oped also carries the wild-type EBFP gene. The usage of the EBFP gene not only allows
the stop-EGFP mouse to detect all possible point mutations arising by either transitions
or transversions,11 but also minimizes the possibility of an immune response to revertant
EGFP. If EGFP is first expressed via a mutation in an adult mouse, the protein could be
recognized as a foreign antigen by the immune system, and cells expressing EGFP killed
by cytotoxic T lymphocytes (CTLs). A strong CTL response against EGFP-expressing cells
has been detected in the BALB/c strain and a moderate CTL response in the C57BL/6
strain.13 Because EBFP differs from EGFP by only a single amino
acid, transgenic mice exposed to EBFP from conception could have
no immune response to revertant EGFP.
The efficiency of the stop-EGFP system for in vivo analysis of
stem cell clonal lineages was demonstrated by applying the system to
the mouse dorsal epidermis.11 Mutations were induced in
stop-EGFP mice using a potent mutagen, ENU (N-ethyl-N-
nitrosourea) to randomly label epidermal cells. In vivo imaging after
several epidermal turnovers revealed stem cell clonal lineages con-
taining three adjacent corneocytes (i.e., epidermal cells belonging
to three adjacent EPUs) suggesting that epidermal cells migrate
horizontally to adjacent EPUs.11 Thus, a single stem cell is capable
of providing epidermal cells for multiple adjacent EPUs, which
contradicts the classical EPU model14-16 but is consistent with other
recent reports17,18 (see Fig. 1 for illustration). In other words, this
finding suggests the actual proliferative compartment in the epider-
mis may be larger than a single EPU; several EPUs might constitute
a large proliferative compartment whereby multiple stem cells of
different EPUs cooperatively provide epidermal cells for the compart-
ment as a whole. The in vivo imaging data also appear to suggest that
epidermal cells can migrate between EPUs not only along the basal
layer, but also above the basal layer. Optical sectioning of cell lineages
(e.g., see Fig. 3 in ref. 11) shows no green fluorescent signal in the
basal layer beneath one of three adjacent green fluorescent corneocytes.
This finding is best explained by horizontal migration of epidermal
cells above the basal layer (i.e., in the suprabasal layers). If epidermal
cells migrate along the basal layer, in this case, the basal cells must
turn off transgene expression during horizontal migration and then
restore gene expression during vertical migration for terminal differ-
entiation, which seems very unlikely.
More recent studies that we have carried out using additional
stop-EGFP mice show that the number of adjacent corneocytes that
a stem cell clonal lineage can produce is dynamic. Epidermal stem
cell clonal lineages containing 1–4 adjacent corneocytes have now
been detected more than six weeks post-ENU administration (i.e.,
after more than three epidermal turnovers) suggesting that the number
of EPUs that a single stem cell can contribute to might be stochastic
(unpublished data). One important advantage of using our stop-
EGFP system in cell lineage studies is that the system can be used for
repeated analyses of the same clonal cell lineages over time, which
could allow one to study the dynamics of the clonal development of
a particular cell lineage. In a new set of studies carried out recently,
we have successfully performed repeated in vivo imaging of the same
stem cell clonal lineages in the epidermis (unpublished data). At
eight weeks post-ENU administration, we performed in vivo imaging
of dorsal skin of two stop-EGFP mice and found two epidermal
stem cell clonal lineages (Fig. 2A and C). Four days later, the same
cell lineages were imaged again. The second imaging showed that
during the four days, the cell lineage shown in Figure 2A expanded
from containing three adjacent corneocytes to four adjacent corneo-
cytes (Fig. 2B), while the size of the cell lineage shown in Figure 2C
remained the same (Fig. 2D). These data strongly demonstrate that
it is feasible to carry out repeated observations on stem cell clonal
lineages over time in a live mouse.
Cell fate mapping using the stop-EGFP transgenic mouse, which
generates clonal cell lineages via mutation, is expected to be useful in
revealing the potential of single stem cells to provide cells to replenish
other cellular compartments, or to produce cells of diverse tissue
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Figure 1. The two opposing models for a stem cell clonal lineage in the
mouse dorsal epidermis. The classical EPU model proposes that an EPU is a
clonal unit of cellular proliferation. According to the EPU model, a single
stem cell having undergone a mutation at the premature stop codon of the
stop-EGFP gene should generate only one green fluorescent EPU (A), which
occupies area of a single corneocyte on the skin surface (B). The opposing
model proposes that epidermal cells can migrate to adjacent EPUs and a sin-
gle stem cell can provide epidermal cells for more than one EPU. The find-
ing of epidermal stem cell clonal lineages containing three adjacent cor-
neocytes (i.e., epidermal cells belonging to three adjacent EPUs) in our
study11 strongly supports the latter model. A stem cell clonal lineage detect-
ed in our study (shown in green) is schematically represented (C), which con-
tained three adjacent corneocytes on the skin surface (D).
Table 1 FATE MAPPING TECHNIQUES CURRENTLY USED IN CELL LINEAGE STUDIES
Method Advantages Disadvantages Refs.
Labeling with vital dyes Easy to apply Label many cells simultaneously; signals are diluted by cell division 27,28
Labeling with tritiated thymidine Easy to apply Label many cells simultaneously; diluted by cell division; can only label 29
(3H-TdR) or bromodeoxyuridine (BrdU) dividing cells
Infection of replication-deficient Permanent labeling Hard to label single cells; can only label proliferating cells 17,30
retrovirus carrying a reporter gene
Intracellular injection of tracers Can label single cells Hard to label small cells or cells located deep in tissue; signals are 31
diluted by cell division
The Dlb-1 (Dolichos biflorus) mouse Single cells are labeled by Can only be applied to the epithelium of the small intestine; requires 24
system random mutation fixation (thus, repeated analyses are not possible)
The laacZ transgenic mouse Single cells are labeled by rare Requires sacrifice of tissue or animal for fixation; hard to 32,33
system spontaneous recombination; can determine when the recombination events occur during
be applied to diverse tissues development
See also refs. 5 and 6.
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types. For example, there has been much interest in determining
how diverse a range of types of differentiated cells a single stem cell
in the respiratory tract,19,20 the liver,21 or the mammary gland22 can
produce, either in a normal steady state or during the regenerative
processes. The stop-EGFP system could be efficiently used to
address these issues of the potential of single stem (or precursor) cells
to generate various types of descendent cells in those tissues.
Furthermore, repeated in vivo imaging of the same tissue sites per-
formed over time might allow a time-lapse study of the generation
of various types of cells from a stem cell clonal lineage. Another
advantage of using GFP as a cell marker is that external imaging of
even single cells in internal organs can be performed.23 Thus, one
might be able to investigate the dynamics of the clonal development
of a cell lineage in an internal organ by repeated external imaging of
the stop-EGFP mouse over time.
In addition to clonal cell lineage studies in adult tissues, the
stop-EGFP system also has the potential to be efficiently applied to
tracing clonal cell lineages in developmental studies. Embryos can be
exposed to ENU in utero at various time points during development
by exposing pregnant mice to the mutagen.24 In our system, cells can
be labeled at a specific time point during development by treatment
with a pulse of the mutagen, thus a clonal cell lineage can be generated
that originated from a precursor cell present in a
specific stage during development. Finally, the
stop-EGFP system could be applied to investi-
gating clonal cell lineages for other organisms.
For example, transgenic fish that ubiquitously
express GFP have been developed.25,26 Thus, a
transgenic fish which carries the stop-EGFP gene
could be generated and used for tracing clonal
cell lineages during development, or in constantly
renewing adult tissues.
One potential weakness of the stop-EGFP
mouse is that the mutation rate at the premature
stop codon within the stop-EGFP gene appears
to be low even after treatment with a potent
mutagen, ENU. This reduces the efficiency with
which labeled cells are generated via mutation in
the stop-EGFP system. Imaging of a 2.5 cm X
2.5 cm area fo dorsal skin of an ENU-treated
stop-EGFP mouse reveals one or fewer stem cell
lineages on average. Thus, imaging of many mice
might be required to detect clonal cell lineages in
a tissue of interest. Repeated treatments with
ENU or another mutagen could help to increase
the expected frequency of mutations at the pre-
mature stop codon. Another strategy is to create
a transgenic mouse carrying a very high copy
number of the stop-EGFP gene. Alternatively, a
transgenic mouse carrying the wild-type EGFP
gene under control of a strong repressor could be
generated in which a mutation at the repressor
gene leads to expression of EGFP. Although the
low mutation rate in the stop-EGFP system may
appear disadvantageous, the extremely low rate of
spontaneous mutation in the stop-EGFP mouse
(e.g., no mutations were detected in the skin,
kidney and liver of untreated stop-EGFP mice) is
an advantage because it enables cells to be labeled
at a specific time point by treatment with a pulse
of mutagen.11 Therefore, imaging experiments carried out after
several tissue turnovers in an adult renewing tissue of mice treated
with a mutagen could allow one to specifically trace cell lineages that
descended from stem cells of the tissue. As well, treatment of embryo
with a pulse of mutagen could allow clonal cell lineages to be generated
that originated specifically at a time point of interest without conta-
mination by cell lineages generated by spontaneous mutations
occurring at other time points during development.
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